Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2009
03/26/2009US20090082251 Mitochondrial DNA variants associated with metabolic syndrome
03/26/2009US20090082250 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
03/26/2009US20090082225 Nucleic acid archiving
03/26/2009US20090082223 Method and kit for the determination of cellular activation profiles
03/26/2009US20090082214 Conjugate probes and optical detection of analytes
03/26/2009US20090081809 Monoclonal antibody specific to dentin-derived heparan sulfate
03/26/2009US20090081808 Device and method for identifying mycotoxins
03/26/2009US20090081802 Method for enriching short-chain nucleic acids
03/26/2009US20090081801 Process for synthesis of pyrrole derivative, an intermediate for atorvastatin
03/26/2009US20090081800 Selective resonance of chemical structures
03/26/2009US20090081799 Analyte evaluation device and analyte evaluation method
03/26/2009US20090081798 Protein S Functional Assay
03/26/2009US20090081797 Reactive surface on a polymeric substrate
03/26/2009US20090081795 Identification of Humans Through Characteristic Compounds Detected in Human Scent
03/26/2009US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase
03/26/2009US20090081773 Microfluidic apparatus for manipulating imaging and analyzing cells of a cytological specimen
03/26/2009US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR
03/26/2009US20090081728 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
03/26/2009US20090081722 Site-specific labeling of affinity tags in fusion proteins
03/26/2009US20090081716 Method for Monitoring the Immune Response and Predicting Clinical Outcomes in transplant recipients
03/26/2009US20090081714 Assays
03/26/2009US20090081713 Peptide biomarkers predictive of renal function decline and kidney disease
03/26/2009US20090081712 ATM-Dependent Phosphorylation of Sp1 Is Involved in the Cellular Response to DNA Damage and Enhances Cellular Survival After DNA Damage
03/26/2009US20090081711 Addressable antibody arrays and methods of use
03/26/2009US20090081710 Method for Cancer Prognosis Using Cellular Folate Vitamin Receptor Quantification
03/26/2009US20090081709 Protein markers of responsiveness to type III receptor tyrosine kinase inhibitors
03/26/2009US20090081708 Methods and Compositions for Detection of Ehrlichia chaffeensis (VLPT)
03/26/2009US20090081707 Human trk receptors and neurotrophic factor inhibitors
03/26/2009US20090081706 Crystalline form of the catalytic domain of aurora 2 kinase and methods of use thereof
03/26/2009US20090081705 Novel peptides and compositions which modulate apoptosis
03/26/2009US20090081704 Compositions, methods and kits for real-time enzyme assays using charged molecules
03/26/2009US20090081703 Method for detecting deep venous thrombosis
03/26/2009US20090081702 Discriminaton of cardiac dysfunction in pregnant females
03/26/2009US20090081701 Method of selective protein enrichment and associated applications
03/26/2009US20090081700 Methods of use of the TACI/TACI-L interaction
03/26/2009US20090081699 Using protein phosphorylation profiles as evaluative tool in diagnosing/prognosing cell proliferative disorders
03/26/2009US20090081698 High throughput cell-based assays, methods of use and kits
03/26/2009US20090081697 Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals
03/26/2009US20090081696 Luminescence enhancer and use thereof
03/26/2009US20090081695 Methods and Compositions for Detection of Ehrlichia chaffeensis (p120)
03/26/2009US20090081694 Modified well plates for molecular binding studies
03/26/2009US20090081693 identifying an inhibitor of an agonist to receptors CCR2 and/or CCR5 (chemokine C-C motif receptor); signal transduction system in the G protein relating signal transduction in the CCL2-CCR2 pathway
03/26/2009US20090081692 Ceramide Kinase Loop
03/26/2009US20090081691 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins
03/26/2009US20090081690 Site-specific labeling of proteins for NMR studies
03/26/2009US20090081689 Reagents and methods to enrich rare cells from body fluids
03/26/2009US20090081685 Methods and compositions for the detection of ovarian disease
03/26/2009US20090081684 sequence-selective nucleic acid detection; polythiophenes containing pendant quaternary ammonium groups that are thermostable and autoclavable; use in DNA or RNA electrochemical or optical detection, or purification; diagnosis of infections or disease
03/26/2009US20090081676 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms
03/26/2009US20090081672 Testing by immunoassay for overexpression which is an indicator of breast cancer; relates to cDNA sequences from a region of amplification on chromosome 20 associated with disease. used in hybridization methods for the identification of chromosomal abnormalities
03/26/2009US20090081660 Compositions and methods for the diagnosis and treatment of tumor
03/26/2009US20090081659 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
03/26/2009US20090081652 Constitutively Translocating Cell Line
03/26/2009US20090081651 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
03/26/2009US20090081649 Diagnostic method for detecting cancer by measuring amount of cytokine like il -6
03/26/2009US20090081638 Immobilisation of Antigenic Carbohydrates to Support Detection of Pathogenic Microorganisms
03/26/2009US20090081415 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process
03/26/2009US20090081345 Identification of Prion Proteins in Milk
03/26/2009US20090081339 Method for producing juice having pre-selected properties and characteristics
03/26/2009US20090081246 Method for isolating hepatitis c virus peptides
03/26/2009US20090081243 Agents and methods for diagnosing stress
03/26/2009US20090081237 Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents
03/26/2009US20090081230 Human cytomegalovirus neutralising antibodies and use thereof
03/26/2009US20090081229 Anti-pro87299 antibodies
03/26/2009US20090081228 Cyr61 compositions and methods
03/26/2009US20090081227 Promotong differentiation of neural stem cells to nerve cells for use in treating injury to central nerve system caused by brain infarction, hemorrhage and/or spinal cord injury
03/26/2009US20090081226 Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies
03/26/2009US20090081225 PIF peptides biologic activities, site of action, and the antibody to detect PIF
03/26/2009US20090081222 Novel splice variants of the egf receptor
03/26/2009US20090081220 Method for diagnosing and treatment of breast cancer and pharmaceuticals composition and kit for same
03/26/2009US20090081219 Human monoclonal antibodies against CD25
03/26/2009US20090081215 Genetic products differentially expressed in tumors and use thereof
03/26/2009US20090081214 Genetic products differentially expressed in tumors and use thereof
03/26/2009US20090081212 Use and targeting of cd98 light-chain proteins in therapies for thyroid hormone disorders
03/26/2009US20090081210 Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells
03/26/2009US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
03/26/2009US20090081207 High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity
03/26/2009US20090081201 Methods for Identifying Compounds For the Treatment of Type 1 Diabetes
03/26/2009US20090081199 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
03/26/2009US20090081197 Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity
03/26/2009US20090081190 Methods for Antibody Library Screening
03/26/2009US20090081189 Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells
03/26/2009US20090081168 Method of forming a peptide-receptor complex with zsig33
03/26/2009US20090081161 Treatment of neoplasms with viruses
03/26/2009US20090081160 Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject
03/26/2009US20090081124 Virus coat protein/receptor chimeras and methods of use
03/26/2009US20090081083 Anti-clogging device and method for in-gel digestion applications
03/26/2009US20090081080 Diagnostic devices for use in the assaying of biological fluids
03/26/2009US20090080607 Device and process for fat analysis
03/26/2009US20090079965 Device for Determining of Properties in a Fluid and/or Constituents Thereof
03/26/2009US20090079964 Optical device components
03/26/2009US20090079963 Device and method for the detection of particles
03/26/2009US20090079962 Tank for an Optical Device for Blood Analysis, Analysis Apparatus Equipped With Such a Tank
03/26/2009US20090078657 Device for separation of particulates from a biological sample
03/26/2009US20090078631 Modular fuel filter assembly
03/26/2009US20090078586 Small Volume In Vitro Analyte Sensor
03/26/2009US20090078574 Charge tags and the separation of nucleic acid molecules
03/26/2009US20090078065 Testing detectors
03/26/2009US20090078032 Method for assessing degradation of a coating on a component by measuring its surface roughness
03/26/2009US20090078030 Test Sensor With a Fluid Chamber Opening